Pregabalin

Lyrica, Ecubalin e altri

Bibliografia - Quali fonti bibliografiche per Pregabalin?

1. Arnold LM. et al., Curr. Med. Res. Opin., 2014, 30 (10), 2069.


2. Arroyo S et al., Epilepsia, 2004, 45 (1), 20.


3. Aust. Adv. Drug Reaction Bull., 2007, 26, 23.


4. Baldwin D.S., Ajel K., Neuropsychiatr. Dis. Treat., 2007, 3 (2), 185.


5. Bensal D. et al., Diabet. Med., 2009, 26 (10), 1019.


6. Beydoun A. et al., Neurology, 2005, 64 (3), 475.


7. Bockbrader H.N. et al., Epilepsia, 2002, 43 Suppl. 8, 145.


8. Bockbrader H.N. et al., Neurology, 2004, 62 Suppl. 5, A314.


9. Bockbrader H.N. et al., Epilepsia, 2011, 52 (2), 405.


10. Bockbrader H.N. et al., Epilepsia, 2011a, 52 (2), 248.


11. Corrigan B. et al., Epilepsia, 2002, 43 (Suppl. 8), 144.


12. Crespo Perez L. et al., Med. Clin., 2008, 103, 157.


13. Crofford L.J. et al., Arthritis Rheum., 2005, 52, 1264.


14. Crofford L.J. et al., Pain. 2008, 136 (3), 419.


15. De Smedt R.H. et al., Br. J. Clin. Pharmacol., 2008, 66 (2), 327.


16. Dooley D.J. et al., Synapse, 2002, 45 (3), 171.


17. Drug and Therapeutics Bulletin, 2006, 44(10), 73.


18. Einarsdottir S. et al., Eur. J. Gastroenterol. Hepatol., 2008, 20, 1049.


19. FDA, Postmarket Drug Safety Information for Patients and Providers, 2008, 31 gennaio.


20. Filipetto F.A. et al., J. Am. Osteopath. Assoc., 2010, 110 (10), 605.


21. Fink K. et al., Neuropharmacology, 2002, 42 (2), 229.


22. French J.A. et al., Neurology, 2003, 60 (10), 1631.


23. Greiner M.J. et al., Neurology, 2004, 62 Suppl. 5, 315.


24. Guberman A. et al., Neurology, 2004, 62 Suppl. 5, 313.


25. Hindmarch I. et al., American psychiatric Association 2002, Annual Meeting: New Research Abstract, 2002, maggio 18-23, Philadelphia, (abstract n 206 e 415).


26. Laville M.A. et al., Rev. Med. Interne, 2008, 29 (2), 152.


27. Lauria-Horner B.A. et al., Expert Opin. Investig. Drugs, 2003, 12 (4), 663.


28. Lesser H. et al., Neurology, 2004.


29. Note AIFA, Bollettino d’Informazione sui Farmaci, 2009, n 5-6.


30. Mease P.J. et al., J. Rheumatol., 2008, 35 (3), 502.


31. Morrell M. et al., Neurology, 2004, 62 (Suppl. 5), A314 (abstract P04.096).


32. Oaklander A.L., Buchbinder B.R., Ann. Neurol., 2005, 58 (2), 309.


33. Orive Calzada A. et al., Med. Clin., 2008, 131, 398.


34. Page R.L. et al., J. Cardiovasc. Med. (Hagerstown), 2008, 9 (9), 922.


35. Pande A.C. et al., Am. J. Psychiatry, 2003, 160, 533.


36. Pande A.C. et al., J. Clin. Psychopharmacol., 2004, 24 (2), 141.


37. Pohl R.B. et al., J. Clin. Psychopharmacol., 2005, 25 (2), 151.


38. Rosenstock J. et al., Pain, 2004, 110, 628.


39. Rowbotham M. et al., J. Pain, 2003, 4 (Suppl. i), 63 (abstract n 846).


40. Russell I.J. et al., Sleep Med., 2009, 10 (6), 604.


41. Scheda Prodotto LYRICA, disponibile on line http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000546/human_med_000894.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124


42. Schwan S. et al., Eur. J. Clin. Pharmacol., 2010, 66 (9), 947.


43. Sharma U. et al., Diabetes, 2000, 49 (Suppl. 1), 167.


44. Sharma U. et al., 153rd American Psychiatric Association Annual Meeting, 2000a, 13-18 maggio, Chicago (abstract n NR531).


45. Siler A.C. et al., J. Pain, 2011, 12 (4), 407.


46. Strojek K. et al., Diabetes, 2004, 53 Suppl. 2, 59 (abstract n 804).


47. Taylor C.P., CNS Drug Rev., 2004, 10 (2), 159.


48. Toelle T. et al., Anasthesiology, 2004, 101, A967.


49. Warner G., Figgitt D.P., CNS Drug, 2005, 19 (3), 265.


50. Willmore L.J., Neurology, 2000, 55 (11 Suppl. 3), S17.


51. Wolfe F. et al., Arthritis. Rheum., 1995, 38, 19.


52. Wood D.M. et al., J. Med. Toxicol., 2010, 6 (4), 435.